Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus
- PMID: 15692970
- DOI: 10.1002/art.20808
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus
Abstract
Objective: To test the association of osteopontin (OPN) polymorphisms with systemic lupus erythematosus (SLE).
Methods: The coding 5' and 3' flanking regions of the OPN gene were scanned for polymorphisms by denaturing high-performance liquid chromatography. A case-control association study was performed in 394 Italian SLE patients and 479 matched controls. OPN serum levels were determined by enzyme-linked immunosorbent assay in 40 patients and 124 controls, and the mean levels were compared between the different OPN genotypes.
Results: Among the 13 detected single-nucleotide polymorphisms (SNPs), alleles -156G (frequency 0.714 versus 0.651; P = 0.006, corrected P [P(corr)] = 0.036) and +1239C (0.377 versus 0.297; P = 0.00094, P(corr) = 0.0056) were significantly increased in the SLE patients compared with the controls. The presence of the associated allele in single or double dose conferred an odds ratio (OR) of 2.35 (95% confidence interval [95% CI] 1.38-4.02) for SNP -156 and an OR of 1.57 (95% CI 1.16-2.13) for SNP +1239. These effects were independent of each other, i.e., not a consequence of linkage disequilibrium between the 2 alleles. The risk associated with a double dose of susceptibility alleles at both SNPs was 3.8-fold higher (95% CI 2.0-7.4) relative to the complete absence of susceptibility alleles. With regard to individual clinical and immunologic features, a significant association was seen between lymphadenopathy and -156 genotypes (overall P = 0.0011, P(corr) = 0.046). A significantly increased OPN serum level was detected in healthy individuals carrying +1239C (P = 0.002), which is indicative of an association between the SLE susceptibility allele and OPN levels.
Conclusion: These data suggest the independent effect of a promoter (-156) and a 3'-untranslated region (+1239) SNP in SLE susceptibility. We can speculate that these sequence variants (or others in perfect linkage disequilibrium) create a predisposition to high production of OPN, and that this in turn may confer susceptibility to SLE.
Similar articles
-
Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.Lupus. 2017 Feb;26(2):132-138. doi: 10.1177/0961203316655214. Epub 2016 Jul 11. Lupus. 2017. PMID: 27307447 Review.
-
Association of osteopontin regulatory polymorphisms with systemic sclerosis.Hum Immunol. 2011 Oct;72(10):930-4. doi: 10.1016/j.humimm.2011.06.009. Epub 2011 Jul 1. Hum Immunol. 2011. PMID: 21763380
-
Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.Gene. 2019 Jun 20;702:107-113. doi: 10.1016/j.gene.2019.02.100. Epub 2019 Mar 19. Gene. 2019. PMID: 30898714
-
Association between a single-nucleotide polymorphism of the angiotensin-converting enzyme gene and susceptibility to systemic lupus erythematosus in the Hainanese population of China.Int J Immunogenet. 2024 Oct;51(5):319-329. doi: 10.1111/iji.12690. Epub 2024 Jul 23. Int J Immunogenet. 2024. PMID: 39044325
-
Association of MBL2 gene polymorphisms and systemic lupus erythematosus susceptibility: A meta-analysis.Int J Rheum Dis. 2021 Feb;24(2):147-158. doi: 10.1111/1756-185X.14017. Epub 2020 Nov 4. Int J Rheum Dis. 2021. PMID: 33146461 Review.
Cited by
-
Quantitative genetic study of the circulating osteopontin in community-selected families.Osteoporos Int. 2011 Aug;22(8):2261-71. doi: 10.1007/s00198-010-1451-7. Epub 2010 Oct 22. Osteoporos Int. 2011. PMID: 20967421
-
Genetics of the type I interferon pathway in systemic lupus erythematosus.Int J Clin Rheumtol. 2013 Dec 1;8(6):10.2217/ijr.13.58. doi: 10.2217/ijr.13.58. Int J Clin Rheumtol. 2013. PMID: 24416080 Free PMC article.
-
Genetic regulation of serum cytokines in systemic lupus erythematosus.Transl Res. 2010 Mar;155(3):109-17. doi: 10.1016/j.trsl.2009.08.012. Epub 2009 Sep 25. Transl Res. 2010. PMID: 20171594 Free PMC article. Review.
-
The impact of osteopontin gene variations on multiple sclerosis development and progression.Clin Dev Immunol. 2012;2012:212893. doi: 10.1155/2012/212893. Epub 2012 Sep 11. Clin Dev Immunol. 2012. PMID: 23008732 Free PMC article.
-
Role of osteopontin in systemic lupus erythematosus.Arch Immunol Ther Exp (Warsz). 2014 Dec;62(6):475-82. doi: 10.1007/s00005-014-0294-x. Epub 2014 Jun 11. Arch Immunol Ther Exp (Warsz). 2014. PMID: 24917428 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous